SCHOTT Pharma AG & Co. KGaA (1SXP) — Working Capital to Net Assets Ratio
SCHOTT Pharma AG & Co. KGaA (1SXP) has a Working Capital to Net Assets ratio of 19.3% as of September 2024. Working capital of €153.12 Million (current assets of €588.60 Million minus current liabilities of €435.48 Million) is measured against net assets of €792.27 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See SCHOTT Pharma AG & Co. KGaA net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SCHOTT Pharma AG & Co. KGaA Working Capital to Net Assets (2020–2024)
This chart shows how SCHOTT Pharma AG & Co. KGaA's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2024, the ratio stands at 19.3%, reflecting working capital of €153.12 Million against net assets of €792.27 Million EUR. Check tangible net worth ratio of SCHOTT Pharma AG & Co. KGaA to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for SCHOTT Pharma AG & Co. KGaA (2020–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for SCHOTT Pharma AG & Co. KGaA from 2020 to 2024, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see SCHOTT Pharma AG & Co. KGaA market cap and net worth.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 19.3% | €153.12 Million | €792.27 Million | €588.60 Million | €435.48 Million | ▲ +2.4 pp |
| 2023 | 16.9% | €117.19 Million | €692.18 Million | €468.34 Million | €351.15 Million | ▼ -15.7 pp |
| 2022 | 32.6% | €231.50 Million | €709.04 Million | €554.52 Million | €323.02 Million | ▲ +18.8 pp |
| 2021 | 13.8% | €57.95 Million | €419.42 Million | €302.16 Million | €244.21 Million | ▲ +4.6 pp |
| 2020 | 9.2% | €29.12 Million | €315.66 Million | €238.98 Million | €209.86 Million | — |